Detalle Publicación

Recomendaciones de la Sociedad Española de Reumatología sobre síndrome antifosfolípido primario. Parte I: Diagnóstico, evaluación y tratamiento

Autores: Caliz Caliz, R. (Autor de correspondencia); Diaz del Campo Fontecha, P.; Galindo Izquierdou, M.; López Longo, F. J.; Martínez Zamora, M. A.; Santamaria Ortiz, A.; Amengual Pliego, O.; Cuadrado Lozano, María José; Delgado Beltran, M. P.; Cervantes Perez, E. C.; Díaz-Cordovés Rego, G.; Garrote Corral, S.; Fuego Varela, C.; Martin Lopez, M.; Nishishinya, B.; Novella Navarro, M.; Pereda Testa, C.; Sanchez Perez, H.; Silva-Fernandez, L.; Martínez Taboada, V. M.
Título de la revista: REUMATOLOGIA CLINICA
ISSN: 1699-258X
Volumen: 16
Número: 2
Páginas: 71 - 86
Fecha de publicación: 2020
Objective: The difficulty in diagnosis and the spectrum of clinical manifestations that can determine the choice of treatment for primary antiphospholipid syndrome (APS) has fostered the development of recommendations by the Spanish Society of Rheumatology (SER), based on the best possible evidence. These recommendations can serve as a reference for rheumatologists and other specialists involved in the management of APS. Methods: A panel of four rheumatologists, a gynaecologist and a haematologist with expertise in APS was created, previously selected by the SER through an open call or based on professional merits. The stages of the work were: identification of the key areas for drafting the document, analysis and synthesis of the scientific evidence (using the Scottish Intercollegiate Guidelines Network [ SIGN] levels of evidence) and formulation of recommendations based on this evidence and formal assessment or reasoned judgement techniques (consensus techniques). Results: 46 recommendations were drawn up, addressing five main areas: diagnosis and evaluation, measurement of primary thromboprophylaxis, treatment for APS or secondary thromboprophylaxis, treatment for obstetric APS and special situations. These recommendations also include the role of novel oral anticoagulants, the problem of recurrences or the key risk factors identified in these subjects. This document reflects the first 21, referring to the areas of: diagnosis, evaluation and treatment of primary APS. The document provides a table of recommendations and treatment algorithms. Conclusions: An update of the SER recommendations on APS is presented. This document corresponds to part I, related to diagnosis, evaluation and treatment. These recommendations are considered tools for decision-making for clinicians, taking into consideration both the decision of the physician experienced in APS and the patient. A part II has also been prepared, which addresses aspects related to obstetric SAF and special situations. Published by Elsevier Espalia, S.L.U.